U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C28H33N7O2
Molecular Weight 504.6381
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DOSIMERTINIB

SMILES

[2H]C([2H])=CC(=O)NC1=CC(NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C34)C([2H])([2H])[2H])=C(OC)C=C1N(C)CCN(C)C

InChI

InChIKey=DUYJMQONPNNFPI-ZFTIYMCPSA-N
InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)/i1D2,5D3

HIDE SMILES / InChI

Molecular Formula C28H33N7O2
Molecular Weight 504.6381
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:06:58 GMT 2023
Edited
by admin
on Sat Dec 16 19:06:58 GMT 2023
Record UNII
K294YWL36N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DOSIMERTINIB
Common Name English
2-Propenamide-3,3-d2, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-[1-(methyl-d3)-1H-indol-3-yl]-2-pyrimidinyl]amino]phenyl]-
Systematic Name English
Code System Code Type Description
PUBCHEM
162623670
Created by admin on Sat Dec 16 19:06:59 GMT 2023 , Edited by admin on Sat Dec 16 19:06:59 GMT 2023
PRIMARY
FDA UNII
K294YWL36N
Created by admin on Sat Dec 16 19:06:59 GMT 2023 , Edited by admin on Sat Dec 16 19:06:59 GMT 2023
PRIMARY
CAS
2403760-70-1
Created by admin on Sat Dec 16 19:06:59 GMT 2023 , Edited by admin on Sat Dec 16 19:06:59 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
IRREVERSIBLE INHIBITOR
METABOLIC ENZYME -> SUBSTRATE
MAJOR
METABOLIC ENZYME -> SUBSTRATE
MINOR
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
IC50
TARGET -> INHIBITOR
Covalently and irreversibly binds to cysteine 797 in the ATP binding site of EGFR, exhibiting 200 times greater potency towards EGFRm/T790M than EGFRWT
IRREVERSIBLE INHIBITOR
IC50
Related Record Type Details
ACTIVE MOIETY
Deuterium-containing dosimertinib that exhibited robust antitumor activity and lower toxicity against NSCLC compared to osimertinib.